Enteralia Bioscience SRL Acquires TFarma SRL
Enteralia Bioscience SRL Acquires TFarma to Strengthen Presence in Italy's Nutraceutical and Medical Device Market
MILAN, ITALY / ACCESSWIRE / November 7, 2024 / Enteralia Bioscience SRL ("Enteralia") is pleased to announce the acquisition of TFarma, a well-established company focused on the sales and marketing of nutraceuticals and medical devices in Italy. This strategic acquisition marks a key milestone in Enteralia's expansion within the Italian market, one of Europe's largest and most influential sectors.
Through this acquisition, Enteralia gains direct access to an established network of over 20 Medical Representatives and Area Managers, who are known for their expertise in the gynecological and gastroenterological fields. The integration of TFarma's product portfolio, which has a strong and consistent revenue track record, will further bolster Enteralia's growth trajectory.
Looking ahead, Enteralia plans to expand its sales network and territorial reach, supported by the introduction of new products from the pipeline of Nemysis Limited, its parent company. These investments are expected to drive substantial revenue and profit growth in the near term.
In addition to expanding the product portfolio, Enteralia is committed to investing in TFarma's existing team, recognizing the critical role they play in the company's success.
"We are delighted to welcome TFarma and its team into the Enteralia family, accelerating our future growth and strengthening our position in the Italian market. The synergy between our product lines, and the experience of TFarma's team, reinforce our strategy and ability to accomplish increasingly ambitious growth" said Antonio Maggi, CEO of Enteralia Bioscience SRL.
Dr. Claudio Ciani and Dr. Giuseppe Giuliani, founding partners of TFarma, shared, "After nearly 20 years since TFarma's founding, we are excited to join Enteralia and its team as we enter a new phase of growth. Our shared focus on women's health and gastroenterology, combined with Enteralia's significant investment in our team and new products from their pipeline, makes Enteralia an ideal partner for our future."
About Enteralia Bioscience SRL
Enteralia Bioscience SRL is an Italian pharmaceutical company and part of the Nemysis Limited group. Its mission is to promote innovative research products from Nemysis, targeting professionals in gynecology and gastroenterology. Enteralia aims to provide effective solutions for prevalent health issues, including iron deficiency, with or without anemia.
About TFarma
TFarma SRL is an Italian pharmaceutical company with a 20-year presence in the gynecological and gastroenterological therapeutic areas. Known for its innovative and effective solutions, TFarma focuses on products that enhance women's health and manage gastroenterological disorders.
Contact Information
Antonio Maggi
Amministratore Delegato
a.maggi@enteralia.it
0280862072
SOURCE: Enteralia Bioscience Srl
View the original press release on newswire.com.
Enteralia Bioscience S.r.l
Subscribe to releases from Accesswire
Subscribe to all the latest releases from Accesswire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Accesswire
Ciavarella Pneumatici Selects ToolsGroup to Revolutionize Supply Chain Planning19.11.2024 08:00:00 CET | Press Release
Leading Italian Tire Distributor Aims to Enhance Demand Forecasting, Inventory Management, and Customer Service MILAN, ITALY and BOSTON, MA / ACCESSWIRE / November 19, 2024 / ToolsGroup, a global leader in retail and supply chain planning and optimization software, has been chosen by Ciavarella Pneumatici, one of Italy's premier B2B tire distributors, to enhance its supply chain planning processes. This strategic partnership aims to improve demand planning efficiency, optimize inventory performance, and elevate service levels. Ciavarella Pneumatici has established itself as a cornerstone in the Italian tire distribution landscape, serving the B2B market with distinction. The company's dynamic approach and commitment to innovation have fueled its expansion to five strategically located warehouses, enabling comprehensive coverage of Central and Southern Italy. Ciavarella's efficient distribution system, coupled with a highly qualified staff, allows for rapid and punctual delivery, settin
Gran Fondo de Ciclismo de Bogotá: Boosting the Local Economy and Creating Jobs17.11.2024 03:00:00 CET | Press Release
Bogotá will host one of the most anticipated sports events of the year: the Gran Fondo Bogotá x Egan. BOGOTÁ, COLOMBIA / ACCESSWIRE / November 17, 2024 / On November 17, Bogotá will host one of the most anticipated sports events of the year: the Gran Fondo de Ciclismo de Bogotá. This celebration of cycling will not only showcase the spirit of the sport but will also generate a significant economic and social benefit in the city, boosting local small and medium-sized businesses as well as the tourism and hospitality sectors. Invitation banner Gran Fondo de Ciclismo de Bogotá. Supporting the Local Economy The Gran Fondo de Ciclismo de Bogotá is making a significant contribution, injecting an impressive $3 billion COP (more than €640,000) into the local economy. This investment directly engages 42 Bogotá-based companies providing essential goods and services, many of them small businesses located in the neighborhoods along the race route. This translates into direct economic growth within
Polaris Renewable Energy Successfully Places USD 175 Million Bond Issue15.11.2024 12:00:00 CET | Press Release
TORONTO, ON / ACCESSWIRE / November 15, 2024 / Polaris Renewable Energy Inc. (TSX:PIF) ("Polaris" or the "Company") announces that it has successfully completed a private placement of USD 175 million senior secured green bonds. The bonds will have a tenor of five years and a fixed coupon rate of 9.5% percent per annum, with interest payable in semi-annual instalments. The bond issue is rated BB- by S&P Global Ratings and is issued under the Company's green finance framework with second-party opinion from Morningstar Sustainalytics. Marc Murnaghan, Chief Executive Officer of Polaris comments: "We are very pleased to successfully place Polaris' inaugural bond issue with strong interest from a wide set of international investors. The bond optimizes the Company's capital structure and secures financing for further growth and increased diversification of cash flow." Settlement of the bonds is expected to occur on or around December 3, 2024, subject to the satisfaction of customary condition
Loar Holdings Inc. Reports Q3 2024 Results, Upward Revision to 2024 and Initial 2025 Guidance13.11.2024 08:00:00 CET | Press Release
WHITE PLAINS, NY / ACCESSWIRE / November 13, 2024 / Loar Holdings Inc. (NYSE:LOAR) (the "Company," "Loar," "we," "us" and "our"), reported record results for the third quarter of 2024. Third Quarter 2024 Net sales of $103.5 million, up 25.0% compared to the prior year's quarter. Net income for Q3 2024 was $8.7 million, up $5.8 million compared to the prior year's quarter. Diluted earnings per share of $0.09. Adjusted EBITDA of $38.1 million, up 31.8% compared to the prior year's quarter. Net income margin for the quarter improved to 8.4% from the prior year's quarter of 3.4%. Adjusted EBITDA Margin for the quarter was 36.8% compared to 34.9% for the prior year's quarter. Adjusted Earnings Per Share of $0.15. "Our third quarter results showcased our continued execution across all four of our strategic value drivers," stated Dirkson Charles, Loar CEO and Executive Co-Chairman of the Board of Directors. "We again achieved record net sales and Adjusted EBITDA, driven by strong demand in bo
Invest in Bogota Starts Working Agenda at the Web Summit in Portugal in Search of Investors12.11.2024 20:50:00 CET | Press Release
LISBON, PORTUGAL / ACCESSWIRE / November 12, 2024 / The Web Summit, one of the most important technology congresses in the world, starts this Monday in Lisbon, Portugal. Invest in Bogota, an investment promotion agency, will be participating in the event to showcase the business opportunities the city has in the field of information technologies. During the event, more than 3,000 companies from 160 countries and more than 1,000 investors are expected to gather, with an attendance that could exceed 70,000 people, according to figures from the organizers. Invest in Bogota, through the entity's Investment Promotion Management, will seek to connect companies, startups and investors that are disruptive, innovative and outstanding in the industry, so that they can consider Bogota as an investment and business destination in Latin America.Panoramic view of Bogota, Colombia. It is worth noting that in recent years, Bogota has positioned itself as a nearshore platform to serve nearby markets, s
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom